MX2010007349A - Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica. - Google Patents
Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica.Info
- Publication number
- MX2010007349A MX2010007349A MX2010007349A MX2010007349A MX2010007349A MX 2010007349 A MX2010007349 A MX 2010007349A MX 2010007349 A MX2010007349 A MX 2010007349A MX 2010007349 A MX2010007349 A MX 2010007349A MX 2010007349 A MX2010007349 A MX 2010007349A
- Authority
- MX
- Mexico
- Prior art keywords
- group
- alkyl
- hydrogen atom
- heterocyclic
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a los compuestos de la fórmula (I) en donde: X es un grupo heterocíclico; R1 es un átomo de hidrógeno, de halógeno, un grupo alcoxi de 1 a 6 átomos de carbono, alquilo de 1 a 6 átomos de carbono, NRaRb; R2 es un átomo de hidrógeno, un grupo alquilo de 1 a 6 átomos de carbono opcionalmente sustituido, alcoxi de 1 a 6 átomos de carbono, un grupo alquenilo de 2 a 6 átomos de carbono, alquinilo de 2 a 6 átomos de carbono, un grupo CO-R5, un grupo co-NR6R7, -CO-O-R8, NR9-CO-R10, NR11R12-, -N=CH-NRaRb, un átomo de halógeno, un ciano, nitro , grupo hidroxiiminoalquil, alcoxiiminoalquilo, alquiltio de 1 a 6 átomos de carbono, alquilsulfinilo de 1 a 6 átomos de carbono, alquilsulfonilo de 1 a 6 átomos de carbono, ((alquilo de de 1 a 6 átomos de carbono))3)sililetinil, un SO2-NR9R10, un grupo fenilo opcionalmente sustituido; R3 es un átomo de hidrógeno, un grupo alquilo de 2 a 6 átomos de carbono, un grupo alcoxi de 1 a 6 átomos de carbono o un átomo de halógeno; R4 es un átomo de hidrógeno, un grupo alquilo de 1 a 4 átomos de carbono, un grupo alcoxi de 1 a 4 átomos de carbono o un átomo de flúor; tales compuestos que se encuentran en forma de una base o una sal de adición de un ácido. La invención puede tener uso terapéutico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0800003A FR2925901B1 (fr) | 2008-01-02 | 2008-01-02 | DERIVES DE N-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
PCT/FR2008/001834 WO2009106749A2 (fr) | 2008-01-02 | 2008-12-31 | Dérivés de n-heterocyclique-imidazo[1,2-a]pyridine-2-carboxamides, leur préparation et leur application en thérapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010007349A true MX2010007349A (es) | 2010-08-18 |
Family
ID=39712153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010007349A MX2010007349A (es) | 2008-01-02 | 2008-12-31 | Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica. |
Country Status (20)
Country | Link |
---|---|
US (1) | US20100317673A1 (es) |
EP (1) | EP2225242A2 (es) |
JP (1) | JP2011509250A (es) |
KR (1) | KR20100099244A (es) |
CN (1) | CN101910172A (es) |
AR (1) | AR070072A1 (es) |
AU (1) | AU2008351927A1 (es) |
BR (1) | BRPI0821992A2 (es) |
CA (1) | CA2710860A1 (es) |
CL (1) | CL2008003933A1 (es) |
CO (1) | CO6331306A2 (es) |
EA (1) | EA201070813A1 (es) |
FR (1) | FR2925901B1 (es) |
IL (1) | IL206671A0 (es) |
MA (1) | MA32059B1 (es) |
MX (1) | MX2010007349A (es) |
TW (1) | TW200934777A (es) |
UY (2) | UY3816Q (es) |
WO (1) | WO2009106749A2 (es) |
ZA (1) | ZA201004643B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2903108B1 (fr) * | 2006-07-03 | 2008-08-29 | Sanofi Aventis Sa | Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique. |
MY172110A (en) | 2010-12-13 | 2019-11-14 | Array Biopharma Inc | Substituted n-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type iii receptor tyrosine kinase inhibitors |
WO2012147890A1 (ja) * | 2011-04-27 | 2012-11-01 | 持田製薬株式会社 | 新規アゾール誘導体 |
JP6284490B2 (ja) * | 2012-12-28 | 2018-02-28 | 株式会社新日本科学 | イミダゾピリジン誘導体を有効成分として含むoct3活性阻害剤又はoct3検出剤 |
US20230085408A1 (en) * | 2019-04-05 | 2023-03-16 | STORM Therapeutics Ltd. | Mettl3 inhibitory compounds |
WO2022074379A1 (en) * | 2020-10-06 | 2022-04-14 | Storm Therapeutics Limited | Mettl3 inhibitory compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260303A (en) * | 1991-03-07 | 1993-11-09 | G. D. Searle & Co. | Imidazopyridines as serotonergic 5-HT3 antagonists |
US7544803B2 (en) * | 2004-01-23 | 2009-06-09 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
FR2903107B1 (fr) * | 2006-07-03 | 2008-08-22 | Sanofi Aventis Sa | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
JP5358962B2 (ja) * | 2007-02-06 | 2013-12-04 | 住友化学株式会社 | 組成物及び該組成物を用いてなる発光素子 |
EP2219646A4 (en) * | 2007-12-21 | 2010-12-22 | Univ Rochester | METHOD FOR MODIFYING THE LIFETIME OF EUKARYOTIC ORGANISMS |
-
2008
- 2008-01-02 FR FR0800003A patent/FR2925901B1/fr not_active Expired - Fee Related
- 2008-06-12 UY UY3816F patent/UY3816Q/es not_active IP Right Cessation
- 2008-12-30 AR ARP080105777A patent/AR070072A1/es unknown
- 2008-12-30 UY UY31587A patent/UY31587A1/es not_active Application Discontinuation
- 2008-12-30 CL CL2008003933A patent/CL2008003933A1/es unknown
- 2008-12-31 BR BRPI0821992-3A patent/BRPI0821992A2/pt not_active IP Right Cessation
- 2008-12-31 CA CA2710860A patent/CA2710860A1/fr not_active Abandoned
- 2008-12-31 MX MX2010007349A patent/MX2010007349A/es not_active Application Discontinuation
- 2008-12-31 EA EA201070813A patent/EA201070813A1/ru unknown
- 2008-12-31 TW TW097151676A patent/TW200934777A/zh unknown
- 2008-12-31 JP JP2010541083A patent/JP2011509250A/ja not_active Withdrawn
- 2008-12-31 WO PCT/FR2008/001834 patent/WO2009106749A2/fr active Application Filing
- 2008-12-31 AU AU2008351927A patent/AU2008351927A1/en not_active Abandoned
- 2008-12-31 KR KR1020107014639A patent/KR20100099244A/ko not_active Application Discontinuation
- 2008-12-31 EP EP08872909A patent/EP2225242A2/fr not_active Withdrawn
- 2008-12-31 CN CN2008801238170A patent/CN101910172A/zh active Pending
-
2010
- 2010-06-28 IL IL206671A patent/IL206671A0/en unknown
- 2010-07-01 ZA ZA2010/04643A patent/ZA201004643B/en unknown
- 2010-07-01 US US12/828,370 patent/US20100317673A1/en not_active Abandoned
- 2010-07-02 CO CO10080861A patent/CO6331306A2/es not_active Application Discontinuation
- 2010-08-02 MA MA33057A patent/MA32059B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CL2008003933A1 (es) | 2010-02-12 |
MA32059B1 (fr) | 2011-02-01 |
ZA201004643B (en) | 2011-09-28 |
CN101910172A (zh) | 2010-12-08 |
BRPI0821992A2 (pt) | 2015-06-23 |
KR20100099244A (ko) | 2010-09-10 |
EP2225242A2 (fr) | 2010-09-08 |
TW200934777A (en) | 2009-08-16 |
CA2710860A1 (fr) | 2009-09-03 |
IL206671A0 (en) | 2010-12-30 |
FR2925901A1 (fr) | 2009-07-03 |
UY31587A1 (es) | 2009-08-03 |
WO2009106749A2 (fr) | 2009-09-03 |
CO6331306A2 (es) | 2011-10-20 |
UY3816Q (es) | 2008-09-30 |
AU2008351927A1 (en) | 2009-09-03 |
WO2009106749A3 (fr) | 2010-05-06 |
FR2925901B1 (fr) | 2011-03-04 |
AR070072A1 (es) | 2010-03-10 |
JP2011509250A (ja) | 2011-03-24 |
US20100317673A1 (en) | 2010-12-16 |
EA201070813A1 (ru) | 2010-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX344669B (es) | Agente antiplaquetas novedoso. | |
WO2008003854A3 (fr) | Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique | |
MY145603A (en) | 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | |
MX2010007351A (es) | Derivados de imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapeutica. | |
NO20091409L (no) | Pyridin-3-yl-derivater som immunmodulerende midler | |
MX2009004920A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1. | |
BRPI1013932A2 (pt) | "derivados de 7-aza-espiro [3.5]nonano-7- carboxilatos, o respectivo preparo e a respectiva aplicação em terapêutica" | |
MX2010007349A (es) | Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica. | |
AU2009253235A8 (en) | Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[1,2- a] pyridines, and preparation and therapeutic use thereof | |
MY144209A (en) | Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors | |
MX2012004453A (es) | Composicion para el control de plagas. | |
RS53080B (en) | AMINOPHOSPHORIC ACID ETHAR DERIVATIVE AND S1P RECEPTOR MODULATOR CONTAINING THE SAME AS THE ACTIVE INGREDIENT | |
TW200607808A (en) | Pyrido-pyrimidine derivatives, preparation thereof and application thereof | |
WO2008136444A1 (ja) | 縮合複素環誘導体 | |
MX2009010731A (es) | Derivados de acido 1-(1-bencilpiperidin-4-il)benzimidazol-5-carbox ilico para el tratamiento de diabetes mellitus. | |
WO2008126901A1 (ja) | 含窒素複素環化合物およびそれを含有する医薬組成物 | |
MX2011012057A (es) | Derivados de ciclopenta [c] pirrolilalquilcarbamatos de heterociclos de 5 miembros, su preparación y su uso en terapéutica. | |
MX2009005447A (es) | Derivados de 2,5-dihidro-3h-pirazolo[4,3-c]piridazin-3-ona sustituidos, su preparacion y uso de los mismos como ligandos de los receptores cb1 de canabinoides. | |
IN2012DN00770A (es) | ||
MY146939A (en) | Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics | |
IN2012DN00768A (es) | ||
WO2008003855A3 (fr) | Utilisation de 2-benzoyl-imidazopyridines en thérapeutique | |
MX2010007353A (es) | Derivados de 6-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas , su preparacion y su aplicacion terapeutica. | |
WO2007000505A3 (fr) | Derives de 4,5-diarylpyrrole, leur preparation et leur application en therapeutique | |
MX2010007348A (es) | Derivados de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion terapeutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |